Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 250-264-8 | CAS number: 30618-84-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Effects on fertility
Link to relevant study records
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 11-July-2006 - 30-Nov-2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and guideline study
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- Dept. of Health, UK
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River (UK) Limited, Margate, Kent.
- Age at study initiation: 8 weeks
- Weight at study initiation: Males: 280 - 379 g; Females: 192 - 260 g
- Housing: All animals were housed in groups of five in polypropylene cages with stainless steel grid floors and tops, suspended over polypropylene trays lined with absorbent paper. During the mating phase, animals were transferred to similar cages on a one male: one female basis.
Following evidence of successful mating, the males were returned to their original cages. Mated females were housed individually during gestation and lactation, in polypropylene cages with solid floors and stainless steel lids, furnished with softwood flakes (Datesand Ltd. Cheshire, UK).
- Diet: Ad libitum
- Water: Ad libitum
- Acclimation period: 28 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 2 °C
- Humidity (%): 55 ± 15 % relative humidity
- Air changes (per hr): 15 x / h
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- - The test material was administered by gavage to three groups each of ten male and ten female rats, for up to fifty-four consecutive days, at dose levels of 15, 50 and 150 mg/kg/day.
- A control group of ten males and ten females was dosed with vehicle alone (Deoxygenated and demineralised water).
- Two recovery groups, each of five males and five females, were treated with the high dose (150 mg/kg/day) or the vehicle alone for forty-three consecutive days and then maintained without treatment for a further fourteen days. - Details on mating procedure:
- - On Day 15, animals were paired on a 1 male: 1 female basis within each dose group for a maximum of fourteen days and smearing commenced.
- Following evidence of mating using vaginal smearing, the males were returned to their original cages and females were transferred to individual cages.
- On completion of mating (during Week 6), five selected males per dose group were evaluated for functional/sensory responses to various stimuli.
- Pregnant females were allowed to give birth and maintain their offspring until Day 5 post partum.
- Evaluation of each litter size, litter weight, mean pup weight, clinical observations and landmark developmental signs were also performed during this period. - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- Groups of ten males and females were treated daily. On Day 15 they were paired for a maximum of 14 days, pregnant females were allowed to give birth and maintain their offsprings until Day 5 post partum.
- Frequency of treatment:
- Each day
- Remarks:
- Doses / Concentrations:
Basis:
nominal conc.
15, 50 and 150 mg/kg bw/day by gavage - No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Positive control:
- none
- Parental animals: Observations and examinations:
- - Clinical Observations: All animals were examined for overt signs of toxicity, ill-health and behavioural change immediately before and after dosing, and one and five hours after dosing, during the working week. Animals were observed immediately before and after dosing, and one hour after dosing at weekends (except for females during parturition where applicable). During the treatment-free period, animals were observed twice daily, morning and afternoon (once daily at weekends). All observations were recorded.
- Functional Observations: Prior to the start of treatment and at weekly intervals thereafter, all non-recovery animals were observed for signs of functional/behavioural toxicity. Functional performance tests were also performed on five selected males and females per non-recovery dose level, prior to termination, together with an assessment of sensory reactivity to various stimuli.
- Behavioural Assessments: Detailed individual clinical observations were performed for each animal using a purpose built arena. The following parameters were observed:
Gait Hyper/Hypothermia, Tremors, Skin colour, Twitches, Respiration, Convulsions, Palpebral closure, Bizarre/Abnormal/Stereotypic behaviour, Urination, Salivation, Defecation, Pilo-erection, Transfer arousal, Exophthalmia, Tail elevation, Lachrymation
- Functional Performance Tests: Purpose-built 44 infra-red beam automated activity monitors were used to assess motor activity. Animals were randomly allocated to the activity monitors. The tests were performed at approximately the same time each day, under similar laboratory conditions.
- Sensory Reactivity: Each animal was individually assessed for sensory reactivity to auditory, visual and proprioceptive stimuli. The following parameters were observed: Grasp response, Touch escape, Vocalisation, Pupil reflex, Toe pinch, Startle reflex, Tail pinch, Blink reflex, Finger approach
- Bodyweight: Individual bodyweights were recorded on Day l (prior to dosing) and then weekly for males until termination. Females were weighed weekly until mating was evident. Bodyweights were then recorded on Days 0, 7, 14 and 20 post coitum, and on Days 1 and 4 postpartum. Recovery animals were weighed on Day 1 (prior to dosing) and then weekly until termination.
- Food Consumption: During the maturation period, weekly food consumption was recorded for each cage of adults. This was continued for males after the mating phase. For females showing evidence of mating, food consumption was recorded for the periods covering Days 0-7, 7-14 and 14-20. For females with live litters, food consumption was recorded on Days 1 and 4 post partum.
- Water Consumption: Water intake was observed daily by visual inspection of water bottles for any overt change.
- Laboratory Investigations: Haematological and blood chemical investigations were performed on five males and five females selected from each non-recovery test and control group on Day 14 (day prior to pairing). Blood samples were obtained from the lateral tail vein. Animals were not fasted prior to sampling.
- Urinalytical investigations were performed on five males selected from non-recovery test and control group during the final week of treatment and on five males selected from each recovery group during the final week of the fourteen day treatment-free period.
- Haematology: The following parameters were measured on blood collected into tubes containing potassium EDTA anti-coagulant:
Haemoglobin (Hb), Erythrocyte count (RBC), Haematocrit (Het), Erythrocyte indices, Total leucocyte count (WBC), Differential leucocyte count, Platelet count (PLT), Reticulocyte count
- Blood Chemistry: The following parameters were measured on plasma from blood collected into tubes containing lithium heparin anti-coagulant:
Urea Calcium (Ca++), Glucose Inorganic phosphorus (P), Total protein (Tot.Prot.), Aspartate aminotransferase (ASAT), Albumin Alanine aminotransferase (ALAT), Albumin/Globulin (A/G) ratio (by calculation), Alkaline phosphatase (AP), Sodium (Na+), Creatinine (Creat), Potassium (K+), Total cholesterol (Chol), Chloride (Cl-), Total bilirubin (Bili)
- Urinalysis: The following parameters were recorded on collected urine: Volume, Ketones, Specific Gravity, Bilirubin, pH, Urobilinogen, Protein, Reducing Substances, Glucose, Blood. - Oestrous cyclicity (parental animals):
- Not examined
- Sperm parameters (parental animals):
- Parameters examined in P male parental generations:
- Testis weight - Litter observations:
- STANDARDISATION OF LITTERS
- Performed on day 4 postpartum: yes
- If yes, maximum of all pups/litter
PARAMETERS EXAMINED
The following parameters were examined in offspring:
- Number of offspring born
- Number and sex of offspring alive recorded daily and reported on Day 1 and 4 postpartum
- Clinical condition of offspring from birth to Day 5 postpartum
- Individual offspring and litter weights on Day 1 and 4 postpartum
- All live offspring were assessed for reflexological response to stimuli by assessing surface righting reflex on Day 1 post partum.
GROSS EXAMINATION OF DEAD PUPS: yes, for external and internal abnormalities - Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals
- Maternal animals: All surviving animals
GROSS NECROPSY
- Gross necropsy consisted of external and internal examinations
ORGAN WEIGHTS:
- These reproductive organs were weighed from all animals that were killed at the end of the study: Ovaries, testes, epididymides
- The following organs, removed from five selected males and parental females from each group that were killed at the end of the study, were dissected free from fat and weighed before fixation: Adrenals, liver, brain, ovaries, epididymides, spleen, heart, testes, kidneys, thymus
HISTOPATHOLOGY:
- From all animals: Ovaries, pituitary, prostate, coagulating gland, seminal vesicles, epididymides, testes, uterus/cervix
- From five selected males and females of each group that were killed at the end of the study: Adrenals, ovaries, aorta (thoracic), pancreas,bone & bone marrow (femur including stifle joint), pituitary, bone & bone marrow (stemum), prostate, brain (including cerebrum, cerebellum and pons), oesophagis, caecturi, rectum, coagulating gland, salivary glands (submaxillary), colon, sciatic nerve, duodenum, seminal vesicles, epididymides, skin (hind limb), eyes, spinal cord (cervical), gross lesions, spleen, heart, stomach, ileum, thyroid/parathyroid Jejunum, trachea, kidneys, testes, liver, thymus, lungs (with bronchi), urinary bladder, lymph nodes (cervical and mesenteric), uterus/cervix, mammary gland, vagina, muscle (skeletal) - Postmortem examinations (offspring):
- Not examined
- Statistics:
- - Haematological, blood chemical, organ weight (absolute and relative to terminal bodyweight),
weekly bodyweight gain, litter weights, offspring bodyweights and quantitative functional
performance data were assessed for dose response relationships by linear regression analysis,
followed by one way analysis of variance (ANOVA) incorporating Levene’s test for homogeneity
of variance.
- Where variances were shown to be homogenous, pairwise comparisons were conducted using Dunnett’s test.
- Where Levene’s test showed unequal variances the data were analysed using non-parametric methods: Kruskal-Wallis ANOVA and Mann-Whitney ‘U’ test.
- The non-parametric methods were also used to analyse implantation loss, offspring sex ratio and
landmark developmental markers.
- The haematology variable basophils was not analysed since consistently greater than 30% of the
data were recorded as the same value. - Reproductive indices:
- Pre-coital interval and fertility indices were calculated
- Offspring viability indices:
- Live birth and viability indices were calculated
- Clinical signs:
- effects observed, treatment-related
- Body weight and weight changes:
- effects observed, treatment-related
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- not examined
- Reproductive function: oestrous cycle:
- no effects observed
- Reproductive function: sperm measures:
- not examined
- Reproductive performance:
- no effects observed
- Dose descriptor:
- NOAEL
- Effect level:
- 150 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Dose descriptor:
- NOAEL
- Effect level:
- 50 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- other: clinical signs; mortality; body weight
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 150 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Remarks on result:
- not determinable due to absence of adverse toxic effects
- Reproductive effects observed:
- not specified
- Conclusions:
- The oral administration of GMT 80% to rats by gavage, at dose levels of 15, 50 and 150 mg/kg bw/d, resulted in no treatment related effects for the males treated with 150 mg/kg bw/d but did result in the death of five females treated with 150 mg/kg bw/d. The NOAEL for systemic toxicity was considered to be 150 mg/kg bw/d for males and 50 mg/kg bw/d for females. The NOAEL for reproductive effects in the males is also 150 mg/kg bw/d as assessed by the absence of adverse effects on fertility or on testicular weight and histopathology. Due to the high matemal mortality and toxicity at 150 mg/kg bw/d in the females, which precludes reproductive assessment at that dose level, the NOAEL for reproductive toxicity in females is 50 mg/kg bw/d.
Reference
CLINICAL SIGNS: The only toxicological significant observations were detected for the two interim death females that were killed in extremis (numbers 73 and 72), these included incidents of tip-toe gait, hunched posture and pilo-erection. One of the females (number 73) also had red/brown staining around the mouth. The deterioration of the females’ condition subsequently led to their termination. No toxicologically significant findings were detected for animals of either sex after the treatment period, or for animals of either sex after the fourteen-day recovery period.
BODY WEIGHT AND WEIGHT GAIN: Females treated with 150 mg/kg/day showed a reduction in group mean bodyweight and bodyweight gain between Day 0 and Day 7 of gestation.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Food consumption was reduced for females treated with 150 mg/kg/day
during Days 0 to 7 of gestation when compared to controls although statistical significance was not achieved.
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No overt intergroup differences were detected for all animals after the
treatment period
HAEMATOLOGY: No treatment-related effects were detected for the haematological parameters investigated
CLINICAL CHEMISTRY: No treatment-related intergroup differences in blood chemical parameters were detected
URINALYSIS: No toxicologically significant effects were detected in treated animals when compared to controls
NEUROBEHAVIOUR: No treatment-related effects were detected for animals of either sex from all treatment groups after the treatment period. Formal behavioural assessments were not carried out for recovery group animals.
ORGAN WEIGHTS: No treatment-related intergroup differences in organ weights were detected for all treated animals after the treatment period
HISTOPATHOLOGY: There were no treatment-related microscopic changes detected for the pituitary or reproductive tissues examined for terminal kill animals after the treatment period.here were five unscheduled deaths during the course of the study. Three females were found dead and two were killed in extremis, all five females were from the 150 mg/kg/day treatment group. With the possible exception of pyometria reported for femal number 72 and focal gastric ulceration for female 73, factors contributing to the death or moribundity in these animals were not evident from histopathological evaluation
- No intergroup differences were observed
CLINICAL SIGNS (OFFSPRING)
- There were no clinically observable signs of test material toxicity detected in offspring from treated animals.
BODY WEIGHT (OFFSPRING)
- Offspring weight at Day 1 of lactation was reduced in the 150 mg/kg/day dose group. This was due to a single dam (number 72) and litter that was killed in extremis on Day 1 of lactation due to the deterioration of the physical health of the dam. The poor condition of the dam led to the reduced bodyweight detected in the animal’s offspring, thus, leading to the reduction in group mean bodyweight for offspring on Day 1 lactation. The offspring bodyweight for the remaining 150 mg/kg/day litters were comparable to controls at Day 4 of lactation. The actual bodyweight and the offspring bodyweight change between Day 1 and 4 of lactation for the remaining litters in the 150 mg/kg/day treatment group were comparable to controls, therefore, this slight difference in offspring bodyweight was considered to be a result of the poor condition of a single dam in the 150 mg/kg/day treatment group and not a representation of reproductive toxicity.
SEXUAL MATURATION (OFFSPRING)
- No treatment-related effects on offspring development were detected.
OTHER FINDINGS (OFFSPRING)
- No intergroup differences were observed for litter size or sex ratio
- No treatment related macroscopic abnormalities were detected for the interim death offspring or for the remaining offspring at terminal kill.
Effect on fertility: via oral route
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 50 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
Additional information
A Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test with the target chemical according to OECD Guideline 422 showed no effects on fertility or on testicular weight of male rats but led to mortality of female rats at the highest dose tested (150 mg/kg bw ). Therefore the relevant NOAEL for reproductive toxicity derived from this study was considered to be 50 mg/kg bw/day. Further information were obtained by a with the target chemical is available.
In a 2-generation reproduction study according to OECD Guideline 416 with the main metabolite thioglycolate (test substance: sodium thioglycolate) a NOEL of 20 mg/kg bw/day for parental toxicity, female fertility and gestation of each generation and for development, growth and survival of the progeny was established. At 40 mg/kg bw/day liver effects in males and females, particularly periportal hepatocellular microvacuolation, and maternal mortality occurred. Effects observed in pups at 40 mg/kg bw/day were likely to be secondary due to the severe maternal toxicity. The No Observed Effect Level (NOEL) for male fertility and female mating behaviour was higher or equal than 40 mg /kg/day. The identified NOEL refers to an equimolar NAEL of 36.4 mg GMT/kg bw/day based on the molecular weight ratio and the level of esterification.
No direct reprotoxic effect could be observed in the OECD 422 with GMT and in the OECD 416 study with NaTG.
Short description of key information:
GMT (CAS: 30618-84-9) OECD 422 reproductive toxicity: NOAEL= 50 mg/kg bw/day
NaTG (CAS: 367-51-1) OECD 416: NOEL= 20 mg/kg bw/day
NAEL= 36.4 mg/kg bw/day
ATG (CAS: 367-51-1) OECD 414: NOEL= 20 mg/kg bw/day
NAEL= 36.4 mg/kg bw/day
Effects on developmental toxicity
Description of key information
target chemical
OECD 422: no direct effects on development of the offsprings
source chemical
CAS: 5421-46-5
OECD 414: maternal toxicity NOAEL= 15 mg/kg bw/day
developmental toxicity NOAEL=75 mg/kg bw/day
developmental toxicity NAEL=142.7 mg/kg bw/day
Effect on developmental toxicity: via oral route
- Dose descriptor:
- NOAEL
- 142.7 mg/kg bw/day
Additional information
During the course of the reproductive screening test according to OECD 422 with the target chemical GMT the poor condition of one dam of the highest dose group led to the reduced bodyweight detected in the animal’s offspring on Day 1 lactation. The offspring bodyweight for the remaining 150 mg/kg/day litters were comparable to controls at Day 4 of lactation. The actual bodyweight and the offspring bodyweight change between Day 1 and 4 of lactation for the remaining litters in the 150 mg/kg/day treatment group were comparable to controls, therefore, this slight difference in offspring bodyweight was considered to be a result of the poor condition of a single dam in the 150 mg/kg/day treatment group and not a representation of developmental toxicity. Supporting evidence can be found in a prenatal developmental toxicity study according to OECD 414 (oral route) with the main metabolite mercaptoacetate (ammonium salt, ATG). Rooting in the bedding material was seen in all rats at 75 mg/kg bw/day. Two animals within this group died on GD 20, one day after the last administration of the test material. These deaths were regarded to be treatment related. All other parameters tested were within the normal range and similar to control values. The NOAELs for maternal and embryo-foetal toxicity were 15 and 75 mg/kg bw/d, respectively. No teratogenic effects were observed.
Taking into account the level of esterification of GMT and the molecular weight of both substances this would represent a NAEL for embryo-foetal toxicity of 142.7 mg GMT/kg bw/day (8/10 x 75 x 166.2/109.2).
Calculation of NAEL: NAEL= (NOAEL x MW GMT/ MW ATG)/ level of esterification
MW GMT: 166.2 g/mol
MW ATG: 109.2 g/mol
Level of esterification of glycerol with thioglycolic acid: 80%Justification for classification or non-classification
The available data on toxicity to reproduction of the test substance does not meet the criteria for classification according to GHS and are therefore conclusive but not sufficient for classification.
No information is available on effects via lactation.
Additional information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.